Clinical trial
Isotretinoin in Preventing Skin Cancer
NCT00025012 · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH · Completed
Key facts
| NCT number | NCT00025012 |
|---|---|
| Title | Isotretinoin in Preventing Skin Cancer |
| Official title | Use Of Isotretinion For Prevention Of Skin Cancer In Patients With Xeroderma Pigmentosum Or Nevoid Basal Cell Carcinoma Syndrome |
| Lead sponsor | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Melanoma (Skin), Non-melanomatous Skin Cancer |
| Intervention type | Drug |
| Interventions | isotretinoin |
| Start date | Jun 1, 1991 |
| Completion | Feb 1, 2004 |
| First posted | Feb 27, 2004 |
| Last update posted | Jun 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: